SLU-PP-332 / 5-Amino-1MQ Capsules – 50.25mg
SLU-PP-332 / 5-Amino-1MQ Capsules
This pairing is often explored for its potential impact on metabolic regulation, energy pathways, and cellular activity in research studies. The formulation offers researchers a convenient option for advanced study applications.
$200.00 / month
SLU-PP-332 / 5-Amino-1MQ Capsules combine two separately characterized small-molecule research compounds, supplied by Advanced Peptide Institute at 99% purity for laboratory research use only. This 50.25mg-per-capsule formulation is intended exclusively for qualified researchers studying ERR-receptor and NNMT-enzymatic pathway interactions in controlled laboratory settings.
What is SLU-PP-332 / 5-Amino-1MQ Capsules?
This formulation combines SLU-PP-332, a synthetic pan-agonist of the estrogen-related receptor (ERR) family studied for its interaction with mitochondrial gene-expression pathways, with 5-Amino-1MQ, a selective inhibitor of nicotinamide N-methyltransferase (NNMT) studied for its interaction with cellular methylation and NAD+-metabolism pathways. Researchers combine these two compounds in a single research formulation to examine the intersection between receptor-level transcriptional signaling (via ERR agonism) and enzymatic-pathway modulation (via NNMT inhibition) within the same cell-based laboratory model. This dual-mechanism design allows laboratories to study receptor-level and enzymatic-level pathway engagement side by side within one research protocol. Advanced Peptide Institute’s combination capsules are formulated to a consistent 50.25mg total dose per capsule and supplied strictly for laboratory and in vitro research applications.
Research Applications
SLU-PP-332 / 5-Amino-1MQ Capsules are studied within laboratory research examining the combined interaction of ERR-receptor agonism and NNMT enzymatic inhibition on cellular energy-metabolism signaling networks. Researchers studying mitochondrial biogenesis pathways use SLU-PP-332’s ERR-agonist mechanism alongside 5-Amino-1MQ’s NNMT-inhibition mechanism to probe whether combined pathway engagement produces distinct signaling profiles compared to either compound studied alone. Cell-based metabolic-research models examining methylation-pathway and mitochondrial gene-expression crosstalk reference this combination when studying multi-pathway research designs. Additional research contexts include structure-activity and combination-pharmacology studies comparing single-compound versus multi-compound pathway engagement in laboratory dosing models. This combination is also referenced in laboratory literature exploring crosstalk between transcriptional and enzymatic metabolic-signaling networks. All such investigations are conducted exclusively within controlled laboratory environments.
Purity & Third-Party Testing
Advanced Peptide Institute SLU-PP-332 / 5-Amino-1MQ Capsules are supplied at 99% purity, independently verified through third-party High-Performance Liquid Chromatography (HPLC) testing and mass spectrometry analysis. This dual-verification process confirms both compound identity and exact purity level prior to release for research use. A Certificate of Analysis (COA) is available for every batch at https://advancedpeptideinstitute.com/certificate-of-analysis/, allowing researchers to confirm the specifications of the exact batch received.
Storage & Handling
Store SLU-PP-332 / 5-Amino-1MQ Capsules in a cool, dry place away from direct sunlight, heat, and moisture to preserve compound stability. Keep the container tightly sealed between uses and out of reach of children. Handle capsules in accordance with standard laboratory safety protocols and institutional research-handling guidelines.
Frequently Asked Questions
What purity is Advanced Peptide Institute SLU-PP-332 / 5-Amino-1MQ Capsules?
Advanced Peptide Institute SLU-PP-332 / 5-Amino-1MQ Capsules is supplied at 99% purity, verified by independent third-party HPLC testing and mass spectrometry. A Certificate of Analysis is available for every batch at https://advancedpeptideinstitute.com/certificate-of-analysis/.
How should SLU-PP-332 / 5-Amino-1MQ Capsules be stored?
Store in a cool, dry place away from direct sunlight and moisture. Keep out of reach of children.
What compounds are in this formulation?
This formulation combines SLU-PP-332, studied for its interaction with estrogen-related receptor (ERR) pathways, with 5-Amino-1MQ, studied for its interaction with NNMT enzymatic pathways.
Published laboratory research on SLU-PP-332 is indexed on PubMed.
Related Research Compounds: Limitless Capsules • BPC-157 Capsules – 500mcg • Browse all Capsules research compounds • Certificate of Analysis
For research use only. Not for human consumption. Not evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.